Kiora Pharmaceuticals Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: KPRX
Share price (10/1/26): $2.58
Market cap (10/1/26): $11.4 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 42 pages Stock Purchase Agreement Among Eyegate Pharmaceuticals, Inc. and the Stockholders of Bayon Therapeutics, Inc. Dated as of October 21, 2021 Stock Purchase Agreement

from 8-K 61 pages Share Purchase Agreement Among Eyegate Pharmaceuticals, Inc. and the Shareholders of Panoptes Pharma GES.M.B.H Dated as of December 18, 2020 Share Purchase Agreement

from 8-K 90 pages Stock Purchase Agreement Among Eyegate Pharmaceuticals, Inc. and the Stockholders of Jade Therapeutics, Inc. Dated as of March 7, 2016